US based NEXVOO Announces the Availability of Additional FDA and CE PPE

NEXVOO® operates a Certified Healthcare Factory in Xiamen, China that provides FDA and CE Certified Masks, Gowns, Face Guards, Hand Sanitizer, IR Thermometers, Goggles and More

NEXVOO announces that it is assisting with the US and global pandemic by expanding its resources to offer additional PPE products into the US.

John Gayman, President of NEXVOO®, stated “The current pandemic is causing massive global shortages.  It is humbling to be in a position to help supply these products that are helping to control the spread and transmission of the COVID19 virus and potentially save lives.”

Steven Schmidt, Vice President says, “I’m very proud of the work our team is doing, to assist frontline workers that are in the line of fire. It is inspiring, to see the commitment of Healthcare Leadership and Government Organizations who are working so efficiently in this time of great need.”

To get direct sourcing, please visit https://www.nexvoostore.com. For questions please email the company at  support@nexvooinc.com.

 

SourceNEXVOO®

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”